Document is current
Any future updates will be listed below
-
Authors
Espinoza-Vinces, Christian
Martínez, Marlon Cantillo
Atorrasagasti-Villar, Ainhoa
Rodríguez, María del Mar Gimeno
Ezpeleta, David
Irimia, Pablo
- License Information
-
More Information
Article History
Received: 30 June 2025
Accepted: 21 August 2025
First Online: 2 September 2025
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare no competing interests. Dr. Pablo Irimia has received personal fees for Speaker/travel grants from Teva, Allergan/Abbvie, Eli Lilly, Organon, Lundbeck, Novartis, Dr. Reddy’s and Pfizer.
